Gastroduodenal ulceration following active immunization with prostaglandin E2 in dogs. Role of gastric acid secretion.
In this study we present evidence to suggest that gastroduodenal mucosal defects may occur in gastric fistula dogs actively immunized with PGE2-thyroglobulin conjugate. One of four PGE2-immunized dogs developed a chronic pyloroduodenal ulcer with penetration into the pancreas and the other three had endoscopic evidence of gastric and/or duodenal erosions. In contrast, no gastroduodenal mucosal defects were seen in control dogs immunized with thyroglobulin alone. Occurrence of gastroduodenal ulcers or erosions was temporally related to formation of specific antibody to PGE2 suggesting that PGE2 antibody may be responsible for lesion formation. An increase in gastric acid secretion was not observed in PGE2-immunized dogs. Thus, it is likely that mucosal defects occur as a result of an impairment of PGE2-mediated mucosal defense mechanisms. Since gastroduodenal lesions can be visualized by endoscopy, the dog may prove to be useful in studying the role of endogenous PG in ulcer diseases.
D000818:Animals; D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology*; D015232:Dinoprostone; D004285:Dogs; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000473:pathology; D005773:Gastroscopy; D007114:Immunization; D007413:Intestinal Mucosa / Q000473:pathology; D010418:Pentagastrin / Q000494:pharmacology; D010437:Peptic Ulcer / Q000209:etiology* / Q000473:pathology; D011453:Prostaglandins / Q000276:immunology; D011458:Prostaglandins E / Q000276:immunology*; D013929:Thromboxane B2 / Q000276:immunology
D001323:Autoantibodies; D011453:Prostaglandins; D011458:Prostaglandins E; D013929:Thromboxane B2; D010418:Pentagastrin; D015232:Dinoprostone